middle.news
How PYC-002 Could Revolutionize Treatment for Phelan-McDermid Syndrome
9:30am on Monday 13th of October, 2025 AEDT
•
Biotechnology
Read Story
How PYC-002 Could Revolutionize Treatment for Phelan-McDermid Syndrome
9:30am on Monday 13th of October, 2025 AEDT
Key Points
PYC-002 increases SHANK3 gene expression addressing PMS root cause
Non-human primate studies show safety and effective brain distribution
Pre-clinical data support progression to human clinical trials in 2026
PYC-002 improves neuronal function in patient-derived cells and animal models
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Pyc Therapeutics (ASX:PYC)
OPEN ARTICLE